JPRN-UMIN000012669
Completed
未知
Efficacy and safety of sildenafil in the treatment of pulmonary arterial hypertension (PAH) after cardiac surgery in Japanese pediatric population - a PAH management- - Sildenafil for pulmonary arterial hypertension after pediatric cardiac surgery
Conditionspulmonary hypertension
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- pulmonary hypertension
- Sponsor
- Osaka Medical College
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients with opened chest Patients with ventricular assist device Patients with extracorporeal membrane oxygenation Patients who are judged as inappropriate to include in this study. Patients with chronic lung disease, retinopathy, or gastrointestinal problems Patients who are received Nitrates or nitric oxide donors in non\-intravenous form (oral, sublingual, buccal, transdermal, inhalation or aerosol) within 48 hours prior to receiving study drug treatment or intravenous forms within 2 hours prior to receiving study drug treatment (sildenafil is known to potentiate the hypotensive effects of nitrates; its concurrent use is contraindicated) Patients who are received endothelin antagonists(eg, bosentan) Patients who are received potent cytochrome P450 3A4 inhibitors (eg, erythromycin, ketoconazole, itraconazole, and protease inhibitors) (Use of aprotinin will be allowed; aprotinin does not inhibit cytochrome P450 enzymes) Patients who are received ritonavir or nicorandil.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Safety and Tolerability of Sildenafil in Patients with Eisenmenger PhysiologyEisenmenger Syndrome (pulmonary hypertension due to congenital heart disease)MedDRA version: 8.1Level: LLTClassification code 10058554Term: Eisenmenger's syndromeEUCTR2006-004705-26-GBImperial College London12
Active, not recruiting
Phase 1
Evaluation of the efficacy of sildenafil on the functional capacity of patients with heart failure with preserved ejection fraction. A randomized, double blind, parallel group and placebo-controlled clinical trial.EUCTR2011-001674-25-ESFrancisco J. González Vílchez100
Recruiting
Phase 3
The effect of sildenafil and metformin on sexual functioIRCT20160524028038N16Bandare-abbas University of Medical Sciences108
Recruiting
Phase 3
The effect of sildenafil and melatonin on sexual functioIRCT20160524028038N13Yasouj University of Medical Sciences216
Active, not recruiting
Phase 1
Assessment of the effects of two different formulations of the same drug on the ability to obtain and maintain an erection which is adequate for satisfying sexual activityEUCTR2018-001418-14-ITMBERTO I - POLICLINICO DI ROMA118